659 related articles for article (PubMed ID: 12915637)
21. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
Serri O; Beauregard C; Hardy J
J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
[TBL] [Abstract][Full Text] [Related]
22. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M; Motiei-Langroudi R
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I; Cabuk B; Gokbel A; Selek A; Cetinarslan B; Anik Y; Ceylan S
World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
[TBL] [Abstract][Full Text] [Related]
24. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly.
Kim JH; Hur KY; Lee JH; Lee JH; Se YB; Kim HI; Lee SH; Nam DH; Kim SY; Kim KW; Kong DS; Kim YH
World Neurosurg; 2017 Aug; 104():272-278. PubMed ID: 28465267
[TBL] [Abstract][Full Text] [Related]
25. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S; Jacob KS; Pratheesh R; Chacko AG
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[TBL] [Abstract][Full Text] [Related]
26. Factors determining the long-term outcome of surgery for acromegaly.
Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
[TBL] [Abstract][Full Text] [Related]
27. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.
Nomikos P; Buchfelder M; Fahlbusch R
Eur J Endocrinol; 2005 Mar; 152(3):379-87. PubMed ID: 15757854
[TBL] [Abstract][Full Text] [Related]
28. Assessment of long-term remission of acromegaly following surgery.
Krieger MD; Couldwell WT; Weiss MH
J Neurosurg; 2003 Apr; 98(4):719-24. PubMed ID: 12691394
[TBL] [Abstract][Full Text] [Related]
29. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission.
Rees DA; Hanna FW; Davies JS; Mills RG; Vafidis J; Scanlon MF
Clin Endocrinol (Oxf); 2002 Apr; 56(4):541-51. PubMed ID: 11966748
[TBL] [Abstract][Full Text] [Related]
31. Improvement in remission rates of the first operation in acromegalic patients.
Demir O; Gedik V; Corapcioglu D; Emral R; Unlu MA; Erdogan MF; Gullu S; Uysal AR; Baskal N
Turk Neurosurg; 2012; 22(5):645-50. PubMed ID: 23015345
[TBL] [Abstract][Full Text] [Related]
32. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
[TBL] [Abstract][Full Text] [Related]
33. Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly.
Nishioka H; Fukuhara N; Yamaguchi-Okada M; Takeshita A; Takeuchi Y; Yamada S
Endocr J; 2017 Nov; 64(11):1073-1078. PubMed ID: 28835593
[TBL] [Abstract][Full Text] [Related]
34. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
Bellut D; Hlavica M; Schmid C; Bernays RL
Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
[TBL] [Abstract][Full Text] [Related]
35. Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations.
Jahangiri A; Wagner J; Han SW; Zygourakis CC; Han SJ; Tran MT; Miller LM; Tom MW; Kunwar S; Blevins LS; Aghi MK
J Neurosurg; 2014 Jul; 121(1):67-74. PubMed ID: 24834943
[TBL] [Abstract][Full Text] [Related]
36. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis].
Boeving A; Borba LA; Rodrigues AM; Orichowski EB; Paz Filho GJ; Santos CM; Boguszewski CL
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212
[TBL] [Abstract][Full Text] [Related]
37. The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
Thomale UW; Stover JF; Unterberg AW
Zentralbl Neurochir; 2005 Aug; 66(3):126-32; discussion 132. PubMed ID: 16116555
[TBL] [Abstract][Full Text] [Related]
38. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
[TBL] [Abstract][Full Text] [Related]
39. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
[TBL] [Abstract][Full Text] [Related]
40. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.
Attanasio R; Epaminonda P; Motti E; Giugni E; Ventrella L; Cozzi R; Farabola M; Loli P; Beck-Peccoz P; Arosio M
J Clin Endocrinol Metab; 2003 Jul; 88(7):3105-12. PubMed ID: 12843150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]